Company news
Vaxcyte, Inc. (NASDAQ:PCVX) news
Every Vaxcyte, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases — page 3
Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its Board of Directors
October 27, 2021
Canbud Appoints New Board Member and Provides Acquisition Update
October 7, 2021
Vaxcyte to Present at Guggenheim 2nd Annual Vaccine and Infectious Disease Conference
September 27, 2021
Vaxcyte to Present at 2021 Cantor Virtual Global Healthcare Conference
September 20, 2021
Vaxcyte Appoints Annie Drapeau and Teri Loxam to Its Board of Directors
September 19, 2021
Vaxcyte Reports Second Quarter 2021 Financial Results and Provides Business Update
August 10, 2021
Vaxcyte Announces Expanded CARB-X Award to Advance Development of VAX-A1, a Vaccine to Prevent Group A Streptococcus Infections
August 4, 2021
Vaxcyte to Present at the Jefferies Virtual Healthcare Conference
May 26, 2021
Vaxcyte Reports First Quarter 2021 Financial Results and Provides Business Update
May 10, 2021
Vaxcyte Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for the Prevention of Invasive Pneumococcal Disease
May 9, 2021
Vaxcyte to Present at BofA Securities 2021 Health Care Conference
May 5, 2021
Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference
April 4, 2021
Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
March 28, 2021
Vaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
March 21, 2021
Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections
January 5, 2021
Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer
December 21, 2020
Vaxcyte to Present at Evercore ISI 3rd Annual HealthCONx Conference
November 23, 2020
Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update
November 11, 2020
Vaxcyte to Present at Jefferies Virtual London Healthcare Conference
November 9, 2020
Vaxcyte to Present at 2020 Cantor Virtual Global Healthcare Conference
September 8, 2020
Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
August 11, 2020
Vaxcyte Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 15, 2020